Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gallstone dissolution therapy with ursodiol. Patient selection.

H Fromm1

  • 1Department of Medicine, George Washington University, Washington, D.C. 20037.

Digestive Diseases and Sciences
|December 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel site for streptomycin resistance in the "530 loop" of chloroplast 16S ribosomal RNA.

Plant molecular biology·2013
Same author

Expression of a truncated tobacco NtCBP4 channel in transgenic plants and disruption of the homologous Arabidopsis CNGC1 gene confer Pb2+ tolerance.

The Plant journal : for cell and molecular biology·2000
Same author

Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters.

Atherosclerosis·2000
Same author

Cyclic-nucleotide- and Ca2+/calmodulin-regulated channels in plants: targets for manipulating heavy-metal tolerance, and possible physiological roles.

Biochemical Society transactions·2000
Same author

Plant succinic semialdehyde dehydrogenase: dissection of nucleotide binding by surface plasmon resonance and fluorescence spectroscopy.

Biochemistry·2000
Same author

Differential regulation of Ca2+/calmodulin-dependent enzymes by plant calmodulin isoforms and free Ca2+ concentration.

The Biochemical journal·2000
Same journal

Upward Mobility: How Mobile Endoscopy Revolutionized Endoscopic Practice in the Developing World.

Digestive diseases and sciences·2026
Same journal

Hematologic and Inflammatory Biomarker-Based Prognostic Assessment in Acute Pancreatitis: The Role of CRP, Procalcitonin, and CRP/Albumin Ratio.

Digestive diseases and sciences·2026
Same journal

Prevalence and Impact of Protein-Calorie Malnutrition in Hospitalized Patients with Steatotic Liver Disease.

Digestive diseases and sciences·2026
Same journal

Development and Validation of a Crotonylation-Related Prognostic Risk Model for Cholangiocarcinoma Based on Integrative Transcriptome Analysis.

Digestive diseases and sciences·2026
Same journal

Cardiac Arrests During Inpatient Gastrointestinal Endoscopic Procedures: A United States Nationwide Assessment.

Digestive diseases and sciences·2026
Same journal

Standardizing Transition of Care for Adolescents with Inflammatory Bowel Disease: The Need for a Unified Approach.

Digestive diseases and sciences·2026
See all related articles

Ursodeoxycholic acid (ursodiol) effectively dissolves gallstones, especially small cholesterol stones, when the gallbladder functions properly. Patient selection is crucial, considering stone type, gallbladder function, and contraindications like pregnancy or severe liver conditions.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Pharmacology

Background:

  • Ursodeoxycholic acid (ursodiol) is an oral agent for gallstone dissolution.
  • It possesses a favorable safety profile.
  • Patient selection is key for successful treatment.

Purpose of the Study:

  • To outline the criteria for selecting patients for ursodiol therapy.
  • To detail the characteristics of suitable gallstones and the importance of gallbladder function.
  • To identify contraindications for ursodiol use.

Main Methods:

  • Evaluation of patient clinical profile.
  • Assessment of gallstone characteristics (size, composition).
  • Assessment of gallbladder function via oral cholecystogram.

Related Experiment Videos

  • Screening tests including liver function tests and imaging (ultrasound, plain film).

    • Main Results:

    • Small, cholesterol-rich gallstones are most amenable to dissolution.
    • A functioning gallbladder is essential for concentrating ursodiol-enriched bile.
    • Contraindications include pregnancy, risk of pregnancy, severe cholestasis, and common bile duct obstruction.

    Conclusions:

    • Successful ursodiol therapy depends on specific patient and stone characteristics.
    • The decision to treat requires a comprehensive clinical assessment and patient consent.
    • Ursodiol offers an effective treatment option for select patients with gallstones.